SOUTH SAN FRANCISCO, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in two upcoming health care conferences in New York, NY.
Morgan Stanley 15th Annual Global Health Care Conference
Linthwaite will participate in a fireside chat presentation on Monday, September 11, at 4:50 pm ET at the Grand Hyatt New York.
Cantor Fitzgerald Healthcare Conference
Linthwaite will also present on Tuesday, September 26, at 4:00 pm ET at the InterContinental New York Barclay Hotel.
Live webcasts of the company’s presentations and subsequent replays may be accessed at http://investors.fluidigm.com/events.cfm. The webcasts will be archived for 90 days following the live presentations.
About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.